Superworth

Dare Bioscience EPS DARE

Diluted earnings per share by quarter and over the last twelve months, from 2013.

Last 12 months, to Jun 30, 2026
−$0.79
Latest quarter, Q2 FY26
−$0.20
Fiscal year 2025
−$1.33

Dare Bioscience's earnings per share was −$0.79 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.20.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.33n/a
FY2024−$0.53n/a
FY2023−$4.08n/a
FY2022−$4.56n/a
FY2021−$8.40n/a
FY2020−$10.92n/a
FY2019−$11.64n/a
FY2018−$20.28n/a
FY2017−$31.92n/a
FY2016−$127.08n/a
FY2015−$187.20n/a
FY2014−$574.80n/a
FY2013−$3108.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.20n/a−$0.79
Q1 FY26−$0.21n/a−$1.04
Q4 FY25−$0.10n/a−$1.33
Q3 FY25−$0.28n/a−$1.92
Q2 FY25−$0.45−130%−$2.19
Q1 FY25−$0.50n/a−$0.22
Q4 FY24−$0.69n/a−$0.53
Q3 FY24−$0.55n/a−$0.53
Q2 FY24$1.52n/a−$1.07
Q1 FY24−$0.81n/a−$3.81
Q4 FY23−$0.69n/a−$4.08
Q3 FY23−$1.09n/a−$5.79

Against its peers

Companies in Drug Manufacturers - General nearest Dare Bioscience's size, closest first, today.

CompanyEPS, 12 monthsGrowth
DAREDare Bioscience−$0.79
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
Peer median$0.36

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Dare Bioscience

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.